Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD.
暂无分享,去创建一个
P. Li | C. Szeto | C. McIntyre
[1] W. Tang,et al. Gut microbiome and its role in cardiovascular diseases , 2017, Current opinion in cardiology.
[2] D. Wheeler,et al. The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease. , 2017, Kidney international.
[3] H. Yadav,et al. Bacterial Translocation from the Gut to the Distant Organs: An Overview , 2017, Annals of Nutrition and Metabolism.
[4] S. Hazen,et al. The Gut Microbiome and Its Role in Cardiovascular Diseases , 2017, Circulation.
[5] L. Marciani,et al. Endotoxemia in Peritoneal Dialysis Patients: A Pilot Study to Examine the Role of Intestinal Perfusion and Congestion , 2017, Peritoneal Dialysis International.
[6] S. Ehrlich. The human gut microbiome impacts health and disease. , 2016, Comptes rendus biologies.
[7] L. Marciani,et al. Patients with chronic kidney disease have abnormal upper gastro‐intestinal tract digestive function: A study of uremic enteropathy , 2016, Journal of gastroenterology and hepatology.
[8] N. Vaziri,et al. Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats. , 2016, American journal of physiology. Renal physiology.
[9] Z. Massy,et al. Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] David W. Johnson,et al. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial. , 2016, Clinical journal of the American Society of Nephrology : CJASN.
[11] D. Kuypers,et al. Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[12] Chih-jen Wu,et al. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure , 2015, PloS one.
[13] B. C. Kwan,et al. Circulating Bacterial-Derived DNA Fragment Level Is a Strong Predictor of Cardiovascular Disease in Peritoneal Dialysis Patients , 2015, PloS one.
[14] N. Vaziri,et al. High Amylose Resistant Starch Diet Ameliorates Oxidative Stress, Inflammation, and Progression of Chronic Kidney Disease , 2014, PloS one.
[15] P. Li,et al. Circulating Endotoxaemia and Frequent Haemodialysis Schedules , 2014, Nephron Clinical Practice.
[16] C. Giachelli,et al. A current understanding of vascular calcification in CKD. , 2014, American journal of physiology. Renal physiology.
[17] B. C. Kwan,et al. Bioimpedance Spectroscopy for the Detection of Fluid Overload in Chinese Peritoneal Dialysis Patients , 2014, Peritoneal Dialysis International.
[18] D. Raj,et al. The gut microbiome, kidney disease, and targeted interventions. , 2014, Journal of the American Society of Nephrology : JASN.
[19] G. Andersen,et al. Expansion of Urease- and Uricase-Containing, Indole- and p-Cresol-Forming and Contraction of Short-Chain Fatty Acid-Producing Intestinal Microbiota in ESRD , 2014, American Journal of Nephrology.
[20] C. Shanahan. Mechanisms of vascular calcification in CKD—evidence for premature ageing? , 2013, Nature Reviews Nephrology.
[21] B. C. Kwan,et al. Effect of Using Ultrapure Dialysate for Hemodialysis on the Level of Circulating Bacterial Fragment in Renal Failure Patients , 2013, Nephron Clinical Practice.
[22] B. C. Kwan,et al. Circulating bacterial-derived DNA fragments as a marker of systemic inflammation in peritoneal dialysis. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] Chi Pang Wen,et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention , 2013, The Lancet.
[24] B. Stecher,et al. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. , 2013, Kidney international.
[25] S. Hazen,et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. , 2013, The New England journal of medicine.
[26] G. Andersen,et al. Chronic kidney disease alters intestinal microbial flora. , 2013, Kidney international.
[27] K. Kalantar-Zadeh,et al. Uremic Plasma Impairs Barrier Function and Depletes the Tight Junction Protein Constituents of Intestinal Epithelium , 2012, American Journal of Nephrology.
[28] J. Craig,et al. High-flux versus low-flux membranes for end-stage kidney disease. , 2012, The Cochrane database of systematic reviews.
[29] Jeanie Park. Cardiovascular Risk in Chronic Kidney Disease: Role of the Sympathetic Nervous System , 2012, Cardiology research and practice.
[30] N. Vaziri,et al. Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[31] P. Li,et al. Endotoxaemia in Haemodialysis: A Novel Factor in Erythropoetin Resistance? , 2012, PloS one.
[32] Vallabh Shah,et al. Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients. , 2012, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[33] T. Greene,et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. , 2012, Kidney international.
[34] P. Li,et al. The impact of antihypertensive drug therapy on endotoxemia in elderly patients with chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[35] S. Yusuf,et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. , 2011, Kidney international.
[36] Cecilia Jernberg,et al. Long-term impacts of antibiotic exposure on the human intestinal microbiota. , 2010, Microbiology.
[37] D. Relman,et al. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation , 2010, Proceedings of the National Academy of Sciences.
[38] S. Mazmanian,et al. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota , 2010, Proceedings of the National Academy of Sciences.
[39] M. Woodward,et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.
[40] B. C. Kwan,et al. ENDOTOXEMIA IS ASSOCIATED WITH BETTER CLINICAL OUTCOME IN INCIDENT CHINESE PERITONEAL DIALYSIS PATIENTS: A PROSPECTIVE COHORT STUDY , 2010, Peritoneal Dialysis International.
[41] Jeffrey N. Weiser,et al. Recognition of Peptidoglycan from the Microbiota by Nod1 Enhances Systemic Innate Immunity , 2010, Nature Medicine.
[42] J. Carrero,et al. Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[43] K. Kalantar-Zadeh,et al. Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[44] H. Clevers,et al. Stem cells, self-renewal, and differentiation in the intestinal epithelium. , 2009, Annual review of physiology.
[45] K. Madsen,et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[46] B. Beutler,et al. Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. , 2008, Immunobiology.
[47] K. Fellermann,et al. Probiotic lactobacilli and VSL#3 induce enterocyte β‐defensin 2 , 2008, Clinical and experimental immunology.
[48] B. C. Kwan,et al. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[49] J. Filep,et al. Neutrophil recognition of bacterial DNA and Toll-like receptor 9-dependent and -independent regulation of neutrophil function , 2008, Archivum Immunologiae et Therapiae Experimentalis.
[50] P. Aljama,et al. Bacterial DNA prolongs the survival of inflamed mononuclear cells in haemodialysis patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[51] J. Ferrières,et al. Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.
[52] J. Alverdy,et al. The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. , 2007, Cell host & microbe.
[53] G Gerken,et al. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. , 2007, Gastroenterology.
[54] J. Brenchley,et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.
[55] C. Ronco,et al. Inflammation and Subclinical Infection in Chronic Kidney Disease: A Molecular Approach , 2006, Blood Purification.
[56] J. Alverdy,et al. Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. , 2006, American journal of physiology. Cell physiology.
[57] B. C. Kwan,et al. Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases. , 2006, Kidney international.
[58] Simon C Watkins,et al. Enterocyte TLR4 Mediates Phagocytosis and Translocation of Bacteria Across the Intestinal Barrier , 2006, The Journal of Immunology.
[59] H. S. Warren,et al. Toll-like receptors. , 2005, Critical care medicine.
[60] T. Tompkins,et al. Probiotics Reduce Enterohemorrhagic Escherichia coli O157:H7- and Enteropathogenic E. coli O127:H6-Induced Changes in Polarized T84 Epithelial Cell Monolayers by Reducing Bacterial Adhesion and Cytoskeletal Rearrangements , 2005, Infection and Immunity.
[61] R. Schindler,et al. Short bacterial DNA fragments: detection in dialysate and induction of cytokines. , 2004, Journal of the American Society of Nephrology : JASN.
[62] P. Delepelaire,et al. Bacterial iron sources: from siderophores to hemophores. , 2004, Annual review of microbiology.
[63] Chi-Sen Chang,et al. Colonic transit time in long-term dialysis patients. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[64] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[65] Anand Kumar,et al. BACTERIAL DNA AND RNA INDUCE RAT CARDIAC MYOCYTE CONTRACTION DEPRESSION IN VITRO , 2004, Shock.
[66] Hsueh-Wen Chang,et al. Diabetes Mellitus, Hyperhomocystinemia and Atherosclerotic Vascular Disease in Taiwanese Chronic Hemodialysis Patients: A Retrospective Study , 2004, Renal failure.
[67] K. Verbeke,et al. Evidence for impaired assimilation of protein in chronic renal failure. , 2003, Kidney international.
[68] Jin-Bor Chen,et al. Hyperhomocystinemia and the Prevalence of Symptomatic Atherosclerotic Vascular Disease in Taiwanese Chronic Hemodialysis Patients: A Retrospective Study , 2003, Renal failure.
[69] Peter Stenvinkel,et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. , 2002, Kidney international.
[70] D. Teitelbaum,et al. Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model , 2002, Pediatric Surgery International.
[71] C. De Simone,et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. , 2001, Gastroenterology.
[72] K. Ateş,et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. , 2001, Kidney international.
[73] E. Ruokonen,et al. Splanchnic perfusion during hemodialysis: Evidence for marginal tissue perfusion , 2001, Critical care medicine.
[74] B. Kirschner,et al. Is Lactobacillus GG Helpful in Children With Crohn’s Disease? Results of a Preliminary, Open-Label Study , 2000, Journal of pediatric gastroenterology and nutrition.
[75] D. Ertem,et al. An uncommon and often overlooked cause of failure to thrive: diencephalic syndrome. , 2000, Journal of pediatric gastroenterology and nutrition.
[76] S. Kiechl,et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. , 1999, Journal of the American College of Cardiology.
[77] Josef Niebauer,et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study , 1999, The Lancet.
[78] I. Hjermann,et al. LPS induced procoagulant activity and plasminogen activator activity in mononuclear cells from persons with high or low levels of HDL lipoprotein. , 1995, Thrombosis research.
[79] I. Mattsby‐Baltzer,et al. Endotoxin levels in sera of elderly individuals. , 1994, Clinical and diagnostic laboratory immunology.
[80] A. Tomasz,et al. CD14 is a pattern recognition receptor. , 1994, Immunity.
[81] M. Reidy,et al. Distortion of endothelial repair. The effect of hypercholesterolaemia on regeneration of aortic endothelium following injury by endotoxin. A scanning electron microscope study. , 1978, Atherosclerosis.
[82] J. Fine,et al. Endotoxaemia in man. , 1972, Lancet.
[83] G. Palade,et al. JUNCTIONAL COMPLEXES IN VARIOUS EPITHELIA , 1963, The Journal of cell biology.
[84] Cases and Observations Illustrative of Renal Disease, Accompanied with the Secretion of Albuminous Urine , 1836, The Medico-chirurgical review.
[85] B. Sampaio-Maia,et al. The Role of the Gut Microbiome on Chronic Kidney Disease. , 2016, Advances in applied microbiology.
[86] M. Geuking,et al. Pathological bacterial translocation in liver cirrhosis. , 2014, Journal of hepatology.
[87] P. Li,et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[88] C. Kay. Letter: Oral contraceptives and venous thrombosis. , 1975, Lancet.
[89] Endotoxaemia in man. , 1972, Lancet.